Conservative Treatment to Prevent Postthrombotic Syndrom in Current Clinical Practice

Current discrepancies among guidelines have created uncertainty on the benefit of compression therapy in deep vein thrombosis. This uncertainty affects motivation of doctors, organisation of care, and patient adherence. However, the current management of deep vein thrombosis, particularly the prevention of postthrombotic syndrom, remains largely conservative and is based on two pillars: anticoagulation therapy and compression therapy.

Keywords

compression therapy - anticoagulation therapy - postthrombotic syndrome - deep vein thrombosis

Schlüsselwörter

Kompressionstherapie - Antikoagulationstherapie - postthrombotisches Syndrom - tiefe Venenthrombose

Publication History

Article published online:
17 February 2025

• Literatur

• 1 Prandoni P, Lensing AW, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 (01) 1-7
• 2 Ende-Verhaar YM, Tick LW, Klok FA. et al. Post-thrombotic syndrome: Short and long-term incidence and risk factors. Thromb Res 2019; 177: 102-109
• 3 Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009; 145 (03) 286-295
• 4 Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960; 1: 1309-1312
• 5 Appelen D, van Loo E, Prins MH. et al. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2017; 9 (09) CD004174
• 6 Tick LW, Kramer MH, Rosendaal FR. et al. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008; 6 (12) 2075-2081
• 7 Kahn SR, Shrier I, Julian JA. et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149 (10) 698-707
• 8 Tick LW, Doggen CJ, Rosendaal FR. et al. Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis. J Thromb Haemost 2010; 8 (12) 2685-2692
• 9 Galanaud JP, Holcroft CA, Rodger MA. et al. Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. J Thromb Haemost 2013; 11 (03) 474-480
• 10 Labropoulos N, Waggoner T, Sammis W. et al. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg 2008; 48 (02) 407-412
• 11 Guo X, Xu H, Zhang J. et al. A systematic review and meta-analysis of risk prediction models for post-thrombotic syndrome in patients with deep vein thrombosis. Heliyon 2023; 9 (11) e22226
• 12 Shi C, Dumville JC, Cullum N. et al. Compression bandages or stockings versus no compression for treating venous leg ulcers. Cochrane Database Syst Rev 2021; 7 (07) CD013397
• 13 de Moraes SilvaMA, Nelson A, Bell-Syer SE. et al. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev 2024; 3 (03) CD002303
• 14 Schuren J, Mohr K. Pascal’s law and the dynamics of compression therapy: a study of healthy volunteers. Int Angiol 2010; 29 (05) 431-435
• 15 Kahn SR, Shapiro S, Wells PS. et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383: 880-888
• 16 Geerts WH, Bergqvist D, Pineo GF. et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (06) 381S-453S
• 17 Brandjes DP, Büller HR, Heijboer H. et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762
• 18 Prandoni P, Lensing AW, Prins MH. et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141 (04) 249-256
• 19 Ziegler S, Schillinger M, Maca TH. et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001; 101 (02) 23-33
• 20 Prandoni P, Lensing AWA, Prins MH. et al. Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux. Haematologica 2022; 107 (01) 303-306
• 21 https://www.nice.org.uk/guidance/ng158/chapter/Recommendations#diagnosis-and-initial-management
• 22 Stevens SM, Woller SC, Baumann KreuzigerL. et al. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. Chest 2024; 166 (02) 388-404
• 23 Kakkos SK, Gohel M, Baekgaard N. et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021; 61 (01) 9-82
• 24 Partsch H, Blättler W. Compression and walking versus bed rest in the treatment of proximal deep venous weight heparin. J Vasc Surg 2000; 32 (05) 861-869
• 25 Roumen-Klappe EM, den Heijer M, van Rossum J. et al. Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effect on the development of the post-thrombotic syndrome. J Thromb Thrombolysis 2009; 27 (04) 400-405
• 26 Arpaia G, Cimminiello C, Mastrogiacomo O. et al. Efficacy of elastic compression stockings used early or after resolution of the edema on recanalization after deep venous thrombosis: the COM.PRE Trial. Blood Coagul Fibrinolysis 2007; 18 (02) 131-137
• 27 Amin EE, Bistervels IM, Meijer K. et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood 2018; 132 (21) 2298-2304
• 28 Ginsberg JS, Hirsh J, Julian J. et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001; 161 (17) 2105-2109
• 29 Jayaraj A, Meissner M. Impact of graduated com- pression stockings on the prevention of post-thrombotic syndrome – results of a randomized controlled trial. Phlebology 2015; 30: 541-548
• 30 Yang X, Zhang X, Yin M. et al. Elastic compression stockings to prevent post-thrombotic syndrome in proximal deep venous thrombosis patients without thrombus removal. J Vasc Surg Venous Lymphat Disord 2022; 10 (02) 293-299
• 31 Aschwanden M, Jeanneret C, Koller MT. et al. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg 2008; 47 (05) 1015-1021
• 32 Mol GC, van de Ree MA, Klok FA. et al. One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial. BMJ 2016; 353: i2691
• 33 Ten Cate-HoekAJ, Amin EE, Bouman AC. et al. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol 2018; 5 (01) e25-e33
• 34 Galanaud JP, Genty-Vermorel C, Barrellier MT. et al. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial. Lancet Haematol 2022; 9 (12) e886-e896
• 35 Prandoni P, Noventa F, Quintavalla R. et al. Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Blood 2012; 119 (06) 1561-1565
• 36 Kolbach DN, Sandbrink MWC, Hamulyak K. et al. Non- pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2004; 1: CD004174
• 37 Musani MH, Matta F, Yaekoub AY. et al. Venouscompression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med 2010; 123: 735
• 38 Tie H-T, Luo M-Z, Luo M-J. et al. Compression therapy in the prevention of postthrombotic syndrome: a systematic review and meta-analysis. Medicine 2015; 94: e1318
• 39 Berntsen CF, Kristiansen A, Akl EA. et al. Compression stockings for preventing the postthrombotic syndrome in patients with deep vein thrombosis. Am J Med 2016; 129: 447.e1-447.e20
• 40 Subbiah R, Aggarwal V, Zhao H. et al. Effect of compression stockings on post thrombotic syndrome in patients with deep vein thrombosis: a meta-analysis of randomised controlled trials. Lancet Haematol 2016; 3: e293-e300
• 41 Burgstaller JM, Steurer J, Held U. et al. Efficacy of com- pression stockings in preventing post-thrombotic syndrome in patients with deep venous thrombosis: a systematic review and metaanalysis. Vasa 2016; 45: 141
• 42 Jin YW, Ye H, Li FY. et al. Compression stockings for prevention of postthrombotic syndrome: a systematic review and meta-analysis. Vasc Endovasc Surg 2016; 50: 328
• 43 Skervin AL, Thapar A, Franchini AJ. et al. Systematic review and meta-analysis of utility of graduated compression stockings in prevention of post-thrombotic syndrome. Eur J Vasc ndovasc Surg 2016; 51: 838
• 44 Avila ML, Montoya M, Lumia C. et al. Compression stockings to prevent post-thrombotic syndrome in adults, a Bayesian meta-analysis. Thromb Res 2019; 182: 20
• 45 Meng J, Liu W, Wu Y. et al. Is it necessary to wear compression stockings and how long should they be worn for preventing post thrombotic syndrome? A meta-analysis of randomized controlled trials. Thromb Res 2023; 225: 79-86
• 46 Nielsen JD, Hermann TS, Fredskilde PCA. Graduated elastic compression stockings in the prevention of post-thrombotic syndrome: A systematic review and meta-analysis. Phlebology 2024; 39 (04) 229-237
• 47 Rinfret F, Gu CS, Vedantham S. et al. New and known predictors of the post thrombotic syndrome: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost 2022; 6 (06) e12796
• 48 Prandoni P, Haas S, Fluharty ME. et al. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry. J Thromb Thrombolysis 2024; 57 (02) 312-321
• 49 Principles of compression in venous disease: a practitioner’s guide to treatment and prevention of venous leg ulcers. Wounds International. 2013 Available from: www.woundsinternational.com
• 50 Moffatt C. Factors that affect concordance with compression therapy. J Wound Care 2004; 13 (07) 291-294
• 51 Mudge E, Holloway S, Simmonds W. et al. Living with venous leg ulceration: issues concerning adherence. BJN 2006; 15 (21) 1166-1171
• 52 Miller C, Kapp S, Newall N. et al. Predicting concordance with multilayer compression bandaging. J Wound Care 2011; 20 (03) 101-112
• 53 Bouman AC, Ten Cate-Hoek AJ, Dirksen CD. et al. Eliciting patients' preferences for elastic compression stocking therapy after deep vein thrombosis: potential for improving compliance. J Thromb Haemost 2016; 14 (03) 510-517
• 54 Schreurs RHP, Joore MA, Ten Cate H. et al. Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective. BMJ Open 2021; 11 (10) e048331
• 55 Raju S, Hollis K, Neglen P. Use of compression stockings in chronic venous disease: patient compliance and efficacy. Ann Vasc Surg 2007; 21: 790-795
• 56 Kankam HKN, Lim CS, Fiorentino F. et al. A summation analysis of compliance and complications of compression hosiery for patients with chronic venous disease or post-thrombotic syndrome. Eur J Vasc Endovasc Surg 2018; 55: 406-416
• 57 Dawson AJ, Akaberi A, Galanaud J-P. et al. Patient-reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome. Res Pract Thromb Haemost 2020; 4: 269-277
• 58 Carolyn C. Post-thrombotic syndrome patient education based on the health belief model: self-reported intention to comply with recommendations. J Wound Ostomy Continence Nurs 2011; 38: 648-654
• 59 Reich-Schupke S, Murmann F, Altmeyer P. et al. Compression therapy in elderly and overweight patients. Vasa 2012; 41: 125-131
• 60 Amin EE, Ten Cate-Hoek AJ, Bouman AC. et al. Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. Lancet Haematol 2018; 5: e512-e519
• 61 Schreurs RHP, Joore MA, De Bruijn-Geraets DP. et al. A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients. PLoS One 2022; 17 (08) e0272566
• 62 Sillen M, Declerck PJ. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. Int J Mol Sci 2021; 22 (07) 3670
• 63 Broderick C, Watson L, Armon MP. Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb. Cochrane Database Syst Rev 2021; 1 (01) CD002783
• 64 Chitsike RS, Rodger MA, Kovacs MJ. et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost 2012; 10 (10) 2039-2044
• 65 van Dongen CJ, Prandoni P, Frulla M. et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3 (05) 939-942
• 66 Hull RD, Pineo GF, Brant R. et al. LITE Trial Investigators. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome. Am J Med 2009; 122 (08) 762-769
• 67 Karathanos C, Nana P, Spanos K. et al. Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; 9 (06) 1568-1576.e1
• 68 Wik HS, Kahn SR, Eriksson H. et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost 2021; 19 (10) 2495-2503
• 69 Bistervels IM, Bavalia R, Beyer-Westendorf J. et al. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin. Res Pract Thromb Haemost 2022; 6 (05) e12748
• 70 Brown C, Tokessy L, Delluc A. et al. Risk of developing post thrombotic syndrome after deep vein thrombosis with different anticoagulant regimens: A systematic review and pooled analysis. Thromb Res 2024; 240: 109057
• 71 Ten Cate H, Guzik TJ, Eikelboom J. et al. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment. Cardiovasc Res 2021; 117 (09) 2030-2044
• 72 Papadaki S, Tselepis AD. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?. Angiology 2019; 70 (10) 896-907
• 73 Borensztajn K, Stiekema J, Nijmeijer S. et al. Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.  Am J Pathol 2008; 172 (02) 309-320
• 74 Bachli EB, Pech CM, Johnson KM. et al. Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts.  J Thromb Haemost 2003; 1 (09) 1935-1944
• 75 Blanc-Brude OP, Archer F, Leoni P. et al. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.  Exp Cell Res 2005; 304 (01) 16-27
• 76 Posthuma JJ, Posma JJN, van Oerle R. et al. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice. Sci Rep 2019; 9 (01) 3909
• 77 Shao J, Zhou Q, Jin F. et al. A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep Venous Thrombosis. J Clin Med 2023; 12 (23) 7450
• 78 Iding AFJ, Limpens TMP, Ten CateH. et al. Chronic inflammatory diseases increase the risk of post-thrombotic syndrome: A prospective cohort study. Eur J Intern Med 2024; 120: 85-91
• 79 The conquer DVT pilot trial, (NCT06440694), Colchicine to Quench the Inflammatory response After Deep Vein Thrombosis.
• 80 Albert MA, Danielson E, Rifai N. et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286 (01) 64-70
• 81 Kessinger CW, Kim JW, Henke PK. et al. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring. PLoS One 2015; 10 (02) e0116621
• 82 San Norberto EM, Gastambide MV, Taylor JH. et al. Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis. Vasa 2016; 45 (02) 133-140
• 83 Delluc A, Ghanima W, Kovacs MJ. et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res 2022; 213: 119-124
• 84 Statins for Venous Event Reduction in Patients With Venous Thromboembolism. (NCT04319627).
• 85 das Graças CdSM, Cyrino FZ, de Carvalho JJ. et al. Protective Effects of Micronized Purified Flavonoid Fraction (MPFF) on a Novel Experimental Model of Chronic Venous Hypertension. Eur J Vasc Endovasc Surg 2018; 55 (05) 694-702
• 86 Selloum L, Bouriche H, Tigrine C. et al. Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation. Exp Toxicol Pathol 2003; 54 (04) 313-318
• 87 Yoo H, Ku SK, Baek YD. et al. Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. Inflamm Res 2014; 63 (03) 197-206
• 88 Kauss T, Moynet D, Rambert J. et al. Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis. Arthritis Res Ther 2008; 10 (01) R19
• 89 Roland IH, Bougelet C, Ninane N. et al. Effect of hydroxyethylrutosides on hypoxial-induced neutrophil adherence to umbilical vein endothelium. Cardiovasc Drugs Ther 1998; 12 (04) 375-381
• 90 Zudin AM, Zasorina MA, Vikhert TA. et al. Ultrasound assessment of alterations in venous haemodynamics in patients with post-thrombotic disease permanently taking phlebotonics. Angiol Sosud Khir 2014; 20 (02) 52-57
• 91 Pascarella L, Lulic D, Penn AH. et al. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Eur J Vasc Endovasc Surg 2008; 35 (01) 102-110
• 92 Lobastov K, Schastlivtsev I, Barinov V. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous hrombosis: Results of a Pilot Clinical Trial. Adv Ther 2019; 36 (01) 72-85
• 93 Iding AFJ, Brans RJB, Ten CateH. et al. Additional rutoside therapy to improve deep vein thrombus resolution (Resolve-DVT): A randomized controlled pilot trial. ISTH; 2024; Bangkok.
• 94 Undas A, Natorska J. Improving fibrinolysis in venous thromboembolism: impact of fibrin structure. Expert Rev Hematol 2019; 12 (08) 597-607
• 95 Noguchi K, Edo N, Miyoshi N. et al. Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa). Thromb Res 2018; 168: 96-101
• 96 Vanassche T, Rosovsky RP, Moustafa F. et al. Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study. J Thromb Haemost 2023; 21 (10) 2929-2940
• 97 (NCT06149520) A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis (SIRIUS).
• 98 Epstein D, Gohel M, Heatley F. et al.  Cost-effectiveness of treatments for superficial venous reflux in patients with chronic venous ulceration.  BJS Open  2018; 2: 203-212